What is InfoBionic.Ai?
InfoBionic.Ai is dedicated to enhancing the efficiency and economic viability of remote patient monitoring for physicians and their patients. The Massachusetts-based company leverages the expertise of its seasoned entrepreneurial team, who possess deep experience in healthcare, IT, medical devices, and mobile technology, with a particular focus on cardiology and remote monitoring solutions. By addressing the complexities inherent in traditional cardiac monitoring processes, InfoBionic.Ai's MoMe® Kardia device aims to streamline diagnosis and decision-making, offering a more effective approach to patient care. The company's strategic focus on optimizing clinical and real-world utility highlights its commitment to innovation within the digital health landscape.
How much funding has InfoBionic.Ai raised?
InfoBionic.Ai has raised a total of $70.7M across 7 funding rounds:
Other Financing Round
$1M
Private Equity
$969K
Other Financing Round
$1.2M
Series B
$8.2M
Unspecified
$50M
Debt
$350K
Debt
$9M
Other Financing Round (2012): $1M with participation from Broadview Ventures
Private Equity (2012): $969K led by Undisclosed
Other Financing Round (2013): $1.2M supported by Cherrystone Angel Group
Series B (2015): $8.2M featuring Excel Venture Management, Zaffre Investments, and Safeguard Scientifics
Unspecified (2018): $50M backed by Zaffre Investments, Safeguard Scientifics, Excel Venture Management, Eagle Investments, and Blue Cross and Blue Shield of Kansas
Debt (2020): $350K with participation from PPP
Debt (2021): $9M led by Horizon Technology Finance
Key Investors in InfoBionic.Ai
Zaffre Investments
Zaffre Investments, LLC, a subsidiary of Blue Cross Blue Shield of Massachusetts, focuses on investing in new products, services, and technologies that improve healthcare delivery. They are active across the healthcare landscape, with a particular interest in health information technology.
Safeguard Scientifics
Safeguard Scientifics is a venture capital and private equity firm that provides capital and expertise to technology-driven businesses, particularly in healthcare and financial services. They aim to fuel the growth of innovative companies.
Excel Venture Management
Excel Venture Management is an investment firm that supports companies in the healthcare sector, likely focusing on innovative technologies and solutions that can drive significant advancements in patient care and operational efficiency.
What's next for InfoBionic.Ai?
With the infusion of major enterprise-level capital, InfoBionic.Ai is poised to further scale its operations and enhance its technological offerings. The company's trajectory suggests a strategic focus on expanding its market reach, potentially through new partnerships or increased sales and marketing efforts. Further development of its remote patient monitoring platform and the MoMe® Kardia device is anticipated, aiming to solidify its position as a leader in cardiac diagnostics. The sustained investment indicates a strong belief in the company's ability to address unmet needs in healthcare technology and improve patient outcomes.
See full InfoBionic.Ai company page
